Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation

McIlroy, G., Nikolousis, E., Abou-Zeid, N. et al. (9 more authors) (2020) Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Leukemia & Lymphoma, 61 (1). pp. 202-205. ISSN 1042-8194

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: Alemtuzumab; Chimerism; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning
Dates:
  • Accepted: 25 July 2019
  • Published (online): 11 August 2019
  • Published: 2 January 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Academic Unit of Medical Education (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 24 Feb 2022 12:45
Last Modified: 24 Feb 2022 12:45
Status: Published
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/10428194.2019.1650177
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics